Literature DB >> 7285283

Gene expression in murine hybrids exhibiting different morphologies and tumorigenic properties.

R Bravo, S J Fey, J E Celis.   

Abstract

[35S]Methionine labelled polypeptides from mouse CLID, hamster ovary cells (CHO, and 7 derived somatic cell hybrids which have segregated CHO chromosomes, were analysed by means of high resolution two-dimensional gel electrophoresis under conditions in which the position of 600 polypeptides could be reproducibly assessed. As judged from the two-dimensional gel electrophoretic patterns (isoelectric focussing (IEF) and non-equilibrium pH gradient electrophoresis (NEPHGE)) gene expression in all the hybrids resembled the mouse CLID parent and with only one exception they all expressed different numbers and intensities of CHO specific polypeptides. Even though some of the hybrids expressed as much as 50% of the total number of CHO specific polypeptides that could be clearly differentiated from those of the mouse parent we failed to find a direct correlation between the expression of any given CHO polypeptide and the morphological or tumorigenic properties of the hybrids. Most CHO specific polypeptides, however, were expressed at lower levels in the hybrids as compared to the parent CHO cells, a fact that may be due to the chromosomal constitution of the hybrids, regulation or both. Similarly, the quantitation of the major cytoskeletal polypeptides present in the hybrids, such as alpha-and beta-tubulin, vimentin, total actin and 3 polypeptides (IEF 12, 24 and 31) present in intermediate filament enriched cytoskeletons, indicate that changes in the relative proportion of any of these proteins is not sufficient to account for the morphology, actin microfilament pattern or tumorigenicity of the hybrids. Co-expression of cytoskeletal proteins in the hybrids could only be demonstrated in the case of the related mouse IEF 24 and hamster IEF 7 polypeptides. In all other cases the cytoskeletal polypeptides co-migrated and presented similar one-dimensional peptide maps. Some principles are emerging concerning the possibility of using somatic cell hybridization in combination with two-dimensional gel electrophoresis to locate genes coding for particular polypeptides on a given chromosome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285283     DOI: 10.1093/carcin/2.8.769

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.

Authors:  J E Celis; A Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Expression of the transformation-sensitive protein "cyclin" in normal human epidermal basal cells and simian virus 40-transformed keratinocytes.

Authors:  J E Celis; S J Fey; P M Larsen; A Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  More than one-third of the discernible mouse polypeptides are not expressed in a Chinese hamster-mouse embryo fibroblast hybrid that retains all mouse chromosomes.

Authors:  R Bravo; R Schafer; K Willecke; H MacDonald-Bravo; S J Fey; J E Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

4.  Changes in the relative proportion of transformation-sensitive polypeptides in giant HeLa cells produced by irradiation with lethal doses of x-rays.

Authors:  J Bellatin; R Bravo; J E Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

6.  Induction of the nuclear protein 'cyclin' in quiescent mouse 3T3 cells stimulated by serum and growth factors. Correlation with DNA synthesis.

Authors:  R Bravo; H Macdonald-Bravo
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.